All Posts
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
31 Oct, 2022 | 13:50h | UTC
Cohort Study | Risk factors of pancreatic cancer in patients with Type 2 DM.
31 Oct, 2022 | 13:47h | UTC
M-A | Comparison of continuous versus intermittent enteral feeding in critically ill patients.
31 Oct, 2022 | 13:48h | UTC
Review | Optimal perfusion targets in cardiogenic shock.
31 Oct, 2022 | 13:45h | UTCOptimal Perfusion Targets in Cardiogenic Shock – JACC: Advances
Commentary on Twitter
#CardiogenicShock (CS) carries marked morbidity and mortality, w/ limited data to guide hemodynamic targets. Randomized #clinicaltrials in CS subsets are necessary to better elucidate optimal #perfusion targets. https://t.co/XpmXmlMdww#JACCAdvances #resuscitation #CardioTwitter pic.twitter.com/VWDEYkQ3nm
— JACC Journals (@JACCJournals) July 4, 2022
Evolving presentation of cardiogenic shock: a review of the medical literature and current practices.
31 Oct, 2022 | 13:46h | UTC
Commentary on Twitter
#CardiogenicShock remains a leading cause of morbidity and mortality among patients with #CardiovascularDisease. In his review, authors sought to survey the medical literature and provide an update on current practice. Read this in full here: https://t.co/lA0Hj9PWaM pic.twitter.com/Vz63n5pWfL
— Cardiology and Therapy (@Cardio_Therapy) August 8, 2022
Cohort Study | Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
31 Oct, 2022 | 13:42h | UTC
Commentary on Twitter
New study shows that a subset of HFrEF patients without atrial fibrillation have a stroke risk equivalent to that of patients with AF who are not anticoagulatedhttps://t.co/AXM5ut2SUV#stroke #heartfailure #HF #cardiotwitter @ESC_Journals @escardio pic.twitter.com/Ppa17U79b8
— EHJ Editor-in-Chief (@ehj_ed) August 26, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A of RCT | Combination of ulinastatin and somatostatin evaluated in acute pancreatitis.
31 Oct, 2022 | 13:44h | UTC
Study | No benefit from frailty screening over a geriatric-assessment-for-all approach in older patients with cancer.
31 Oct, 2022 | 13:40h | UTC
Nonsurgical options for risk reduction of contralateral breast cancer in BRCA mutation carriers with early breast cancer.
31 Oct, 2022 | 13:41h | UTCNonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer – Journal of Clinical Oncology (free for a limited period)
Post-trial follow-up | Pembrolizumab vs. chemotherapy as first-line therapy in PD-L1-expressing non–small-cell lung cancer.
31 Oct, 2022 | 13:39h | UTC
RCT | Effectiveness of rTMS vs. bilateral Theta burst stimulation in older adults with depression.
31 Oct, 2022 | 13:38h | UTCCommentary: Neurostimulation Methods Compared for Treating Depression in Seniors – HealthDay
Commentary on Twitter
Study shows that bilateral theta-burst stimulation achieves a non-inferior reduction in #depression symptoms compared to standard bilateral rTMS, in older adults with treatment-resistant depression https://t.co/S8RZ0Ah3m0 pic.twitter.com/iAzhSj05Vf
— JAMA Psychiatry (@JAMAPsych) September 23, 2022
Post-trial follow-up | Updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab.
31 Oct, 2022 | 13:36h | UTC
Commentary on Twitter
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab https://t.co/hw7Tp9yjdu pic.twitter.com/CqMu2cMqRc
— Blood Journal (@BloodJournal) August 31, 2022
RCT | Sutimlimab in patients with cold agglutinin disease without recent transfusion.
31 Oct, 2022 | 13:37h | UTCEditorial: A virtuosic CADENZA played by sutimlimab – Blood
Commentary: Sutimlimab Shows Efficacy in Patients With CAD Without Recent Transfusion – AJMC
Commentary on Twitter
Read #openaccess article ‘Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial’ recently published in @BloodJournalhttps://t.co/K13e9V1c0K @ASH_Hematology pic.twitter.com/61oqWewcJ2
— Elsevier Hematology (@ELShematology) September 12, 2022
Case Report | Acquired Hemophilia A secondary to an immune checkpoint inhibitor.
31 Oct, 2022 | 13:34h | UTCCommentary: Report Details Rare Case of Acquired Hemophilia A Secondary to Immune Checkpoint Inhibition
Cohort Study | Association of retinal age gap with arterial stiffness and incident cardiovascular disease.
31 Oct, 2022 | 13:32h | UTCAssociation of Retinal Age Gap With Arterial Stiffness and Incident Cardiovascular Disease – Stroke
Related:
Cohort Study | Diverticular disease linked to increased risk of cancer outside the GI tract.
31 Oct, 2022 | 13:33h | UTCCancer risk in patients with diverticular disease: a nationwide cohort study – JNCI: Journal of the National Cancer Institute (link to abstract – $ for full-text)
News Release: Diverticular disease associated with cancer outside gastrointestinal tract – Karolinska Institutet
RCT | Liposomal bupivacaine transversus abdominis plane block did not reduce postoperative pain after abdominal wall reconstruction.
31 Oct, 2022 | 13:30h | UTCThe Efficacy of Liposomal Bupivacaine on Postoperative Pain Following Abdominal Wall Reconstruction: A Randomized, Double-blind, Placebo-controlled Trial – Annals of Surgery (link to abstract – $ for full-text)
Cohort Study | Clinical diagnosis and magnetic resonance imaging in patients with transient and minor neurological symptoms.
31 Oct, 2022 | 13:31h | UTC
Commentary on Twitter
Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study https://t.co/8S9zWuBRYe @mattreed73 @edinburghstroke @EdinUniBrainSci @bleedingstroke @emerge_research @strokeblokeFAST @EdinUniNeuroImg pic.twitter.com/5wjWZS8YwH
— Stroke AHA/ASA (@StrokeAHA_ASA) August 9, 2022
WHO Report | Fungal priority pathogens list to guide research, development and public health action.
28 Oct, 2022 | 13:31h | UTCNews Release: WHO releases first-ever list of health-threatening fungi – World Health Organization
Commentary on Twitter (thread – click for more)
Fungal pathogens can cause illnesses and death.
They are becoming increasingly common and resistant to treatment.Yet, too little is known about them.
The 🆕 WHO fungal priority pathogens list is an important step to boost urgently needed research:
📌 https://t.co/cXgj2HPZIc pic.twitter.com/4LgdIqf4Lo— World Health Organization (WHO) (@WHO) October 25, 2022
WHO | Global status report on physical activity 2022.
28 Oct, 2022 | 13:30h | UTCGlobal status report on physical activity 2022 – World Health Organization
News Release: WHO highlights high cost of physical inactivity in first-ever global report – World Health Organization
Commentary on Twitter
The cost of physical inactivity will reach over USD300 billion in 10 years if governments don’t take urgent action to encourage more physical activity among their populations.
The first-ever WHO Global status report on physical activity 2022 explains 👉https://t.co/eLeRuwqlMb pic.twitter.com/7DBzMEJFIF
— World Health Organization (WHO) (@WHO) October 19, 2022
RCT | Early active mobilization during mechanical ventilation in the ICU did not improve outcomes and increased adverse events.
28 Oct, 2022 | 13:28h | UTCEarly Active Mobilization during Mechanical Ventilation in the ICU – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/NEJM/status/1585246120963604481
RCT | Haloperidol for the treatment of delirium in ICU patients did not significantly improve outcomes.
28 Oct, 2022 | 13:29h | UTCHaloperidol for the Treatment of Delirium in ICU Patients – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In this randomized trial, treatment with haloperidol did not increase the number of days alive and out of the hospital among ICU patients with delirium. #LIVES2022 https://t.co/SCRUg3ff9X pic.twitter.com/0dInueHE76
— NEJM (@NEJM) October 26, 2022
RCT | Spontaneous-breathing trials performed with pressure-support ventilation are no better than trials using a T-piece.
28 Oct, 2022 | 13:25h | UTCSpontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Among patients with a high risk of reintubation, spontaneous-breathing trials performed with pressure-support ventilation did not result in significantly fewer ventilator-free days at day 28 than T-piece trials. #LIVES2022 https://t.co/kqSDe3X89v pic.twitter.com/dCcPxdCWmJ
— NEJM (@NEJM) October 26, 2022
Systematic Review | Support for healthy breastfeeding mothers with healthy term babies.
28 Oct, 2022 | 13:23h | UTCSupport for healthy breastfeeding mothers with healthy term babies – Cochrane Library
Summary: Support for breastfeeding mothers – Cochrane Library
CDC study shows healthcare workers have a low risk of infection after exposure to patients with monkeypox.
28 Oct, 2022 | 13:21h | UTCCommentaries:
Clinicians at Low Risk of Acquiring Monkeypox From Patients – JAMA
Low risk of monkeypox spread noted in health workers – CIDRAP
Risk of Monkeypox Transmission Low in Health Care Settings – HealthDay